Journal of Lipid Research, Vol 34, 49-58, Copyright © 1993 by Lipid Research, Inc.

ARTICLES

Two different allelic mutations in the lecithin:cholesterol acyltransferase (LCAT) gene resulting in classic LCAT deficiency: LCAT (tyr83-->stop) and LCAT (tyr156-->asn)

HG Klein, P Lohse, N Duverger, JJ Albers, DJ Rader, LA Zech, S Santamarina-Fojo and HB Brewer Jr
Molecular Disease Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892.

The molecular defects in the lecithin:cholesterol acyltransferase (LCAT) gene have been identified in a 52-year-old patient with classic LCAT deficiency, presenting with corneal clouding and proteinuria. Plasma total cholesterol was normal, triglycerides were elevated, whereas high density lipoprotein (HDL) cholesterol (8 mg/dl) and plasma cholesteryl esters (6% of total cholesterol) were markedly reduced. Plasma cholesterol esterification rate (pCER) was zero, alpha-LCAT activity, assayed using an HDL-like proteoliposome substrate was reduced to 1.6% of control, and LCAT mass was 3.7% of normal plasma levels. DNA sequence analysis of the proband's LCAT gene identified a C to A substitution, converting tyr83 to a stop codon, and a T to A transition, replacing tyr156 by asn. Restriction analysis of PCR- amplified DNA from the proband, a control and his four children using the enzymes Acc I and Rsa I established that the patient is a compound heterozygote for both mutations. The two children, heterozygous for the stop codon defect, were phenotypically indistinguishable from the two with the tyr156 defect. In vitro expression of LCAT (tyr156-->asn) in human embryonic kidney-293 cells established the functional significance of this mutation. The secreted translation product had only 6% of control mass and no detectable CER; however, the residual LCAT mass of the in vitro expressed LCAT (tyr156-->asn) demonstrated a specific alpha-LCAT activity of 30% of control, suggesting that this amino acid substitution results in a mutant enzyme that retains some enzymic activity, but may be rapidly catabolized. In summary, we have identified two unique defects in the LCAT gene that lead to the expression of classic LCAT deficiency in this kindred.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				M. Nishiwaki, K. Ikewaki, G. Bader, H. Nazih, M. Hannuksela, A. T. Remaley, R. D. Shamburek, and H. B. Brewer Jr Human Lecithin:Cholesterol Acyltransferase Deficiency: In Vivo Kinetics of Low-Density Lipoprotein and Lipoprotein-X Arterioscler. Thromb. Vasc. Biol., June 1, 2006; 26(6): 1370 - 1375. [Abstract] [Full Text] [PDF]

				L. Calabresi, L. Pisciotta, A. Costantin, I. Frigerio, I. Eberini, P. Alessandrini, M. Arca, G. Bittolo Bon, G. Boscutti, G. Busnach, et al. The Molecular Basis of Lecithin:Cholesterol Acyltransferase Deficiency Syndromes: A Comprehensive Study of Molecular and Biochemical Findings in 13 Unrelated Italian Families Arterioscler. Thromb. Vasc. Biol., September 1, 2005; 25(9): 1972 - 1978. [Abstract] [Full Text] [PDF]

				M. E. Brousseau, R. D. Kauffman, E. E. Herderick, S. J. Demosky Jr, W. Evans, S. Marcovina, S. Santamarina-Fojo, H. B. Brewer Jr, and J. M. Hoeg LCAT Modulates Atherogenic Plasma Lipoproteins and the Extent of Atherosclerosis Only in the Presence of Normal LDL Receptors in Transgenic Rabbits Arterioscler. Thromb. Vasc. Biol., February 1, 2000; 20(2): 450 - 458. [Abstract] [Full Text] [PDF]

				S. Jimi, N. Uesugi, K. Saku, H. Itabe, B. Zhang, K. Arakawa, and S. Takebayashi Possible Induction of Renal Dysfunction in Patients With Lecithin:Cholesterol Acyltransferase Deficiency by Oxidized Phosphatidylcholine in Glomeruli Arterioscler. Thromb. Vasc. Biol., March 1, 1999; 19(3): 794 - 801. [Abstract] [Full Text] [PDF]

				F. Peelman, J-L. Verschelde, B. Vanloo, C. Ampe, C. Labeur, J. Tavernier, J. Vandekerckhove, and M. Rosseneu Effects of natural mutations in lecithin:cholesterol acyltransferase on the enzyme structure and activity J. Lipid Res., January 1, 1999; 40(1): 59 - 69. [Abstract] [Full Text]

				S. Adimoolam, L. Jin, E. Grabbe, J.-J. Shieh, and A. Jonas Structural and Functional Properties of Two Mutants of Lecithin-Cholesterol Acyltransferase (T123I and N228K) J. Biol. Chem., December 4, 1998; 273(49): 32561 - 32567. [Abstract] [Full Text] [PDF]

				M. E. Brousseau, J. Wang, S. J. Demosky , Jr., B. L. Vaisman, G. D. Talley, S. Santamarina-Fojo, H. B. Brewer , Jr., and J. M. Hoeg Correction of hypoalphalipoproteinemia in LDL receptor-deficient rabbits by lecithin:cholesterol acyltransferase J. Lipid Res., August 1, 1998; 39(8): 1558 - 1567. [Abstract] [Full Text]

				K. Moriyama, J. Sasaki, Y. Takada, A. Matsunaga, J. Fukui, J. J. Albers, and K. Arakawa A Cysteine-Containing Truncated Apo A-I Variant Associated With HDL Deficiency Arterioscler. Thromb. Vasc. Biol., December 1, 1996; 16(12): 1416 - 1423. [Abstract] [Full Text]

				S. Seguret-Mace, M. Latta-Mahieu, G. Castro, G. Luc, J.-C. Fruchart, E. Rubin, P. Denefle, and N. Duverger Potential Gene Therapy for Lecithin-Cholesterol Acyltransferase (LCAT)–Deficient and Hypoalphalipoproteinemic Patients With Adenovirus-Mediated Transfer of Human LCAT Gene Circulation, November 1, 1996; 94(9): 2177 - 2184. [Abstract] [Full Text]

				J. M. Hoeg, B. L. Vaisman, S. J. Demosky Jr., S. M. Meyn, G. D. Talley, R. F. Hoyt Jr., S. Feldman, A. M. Bérard, N. Sakai, D. Wood, et al. Lecithin:Cholesterol Acyltransferase Overexpression Generates Hyperalpha-lipoproteinemia and a Nonatherogenic Lipoprotein Pattern in Transgenic Rabbits J. Biol. Chem., February 23, 1996; 271(8): 4396 - 4402. [Abstract] [Full Text] [PDF]

				J. A. Kuivenhoven, A. F.H. Stalenhoef, J. S. Hill, P. N.M. Demacker, A. Errami, J. J.P. Kastelein, and P. H. Pritchard Two Novel Molecular Defects in the LCAT Gene Are Associated With Fish Eye Disease Arterioscler. Thromb. Vasc. Biol., February 1, 1996; 16(2): 294 - 303. [Abstract] [Full Text]

				E. Hengstschläger-Ottnad, K. Kuchler, and W. J. Schneider Chicken Lecithin-Cholesterol Acyltransferase J. Biol. Chem., November 3, 1995; 270(44): 26139 - 26145. [Abstract] [Full Text] [PDF]

				B. L. Vaisman, H.-G. Klein, M. Rouis, A. M. Bérard, M. R. Kindt, G. D. Talley, S. M. Meyn, R. F. HoytJr., S. M. Marcovina, J. J. Albers, et al. Overexpression of Human Lecithin Cholesterol Acyltransferase Leads to Hyperalphalipoproteinemia in Transgenic Mice J. Biol. Chem., May 19, 1995; 270(20): 12269 - 12275. [Abstract] [Full Text] [PDF]

				H.-G. Klein, N. Duverger, J. J. Albers, S. Marcovina, H. B. Brewer Jr., and S. Santamarina-Fojo In Vitro Expression of Structural Defects in the Lecithin-Cholesterol Acyltransferase Gene J. Biol. Chem., April 21, 1995; 270(16): 9443 - 9447. [Abstract] [Full Text] [PDF]

				H. Miettinen, H. Gylling, I. Ulmanen, T. A. Miettinen, and K. Kontula Two Different Allelic Mutations in a Finnish Family With Lecithin:Cholesterol Acyltransferase Deficiency Arterioscler. Thromb. Vasc. Biol., April 1, 1995; 15(4): 460 - 467. [Abstract] [Full Text]

				G. Lambert, N. Sakai, B. L. Vaisman, E. B. Neufeld, B. Marteyn, C.-C. Chan, B. Paigen, E. Lupia, A. Thomas, L. J. Striker, et al. Analysis of Glomerulosclerosis and Atherosclerosis in Lecithin Cholesterol Acyltransferase-deficient Mice J. Biol. Chem., April 27, 2001; 276(18): 15090 - 15098. [Abstract] [Full Text] [PDF]